tiprankstipranks
Trending News
More News >
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
Canadian Market

Origin Therapeutics Holdings, Inc. (SPLY) Financial Statements

Compare
3 Followers

Origin Therapeutics Holdings, Inc. Financial Overview

Origin Therapeutics Holdings, Inc.'s market cap is currently C$20.28M. The company's EPS TTM is C$-0.036; its P/E ratio is ―; Origin Therapeutics Holdings, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Sep 22Sep 21
Income Statement
Total Revenue
Gross Profit---
Operating Income
EBITDA-$ -1.45M$ -1.19M
Net Income$ -6.31M$ -1.45M$ -845.51K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―
Total Assets$ 4.22M$ 5.59M$ 7.06M
Total Debt$ 0.00$ 0.00$ 0.00
Net Debt$ -3.77M$ -5.23M$ -6.68M
Total Liabilities$ 2.26M$ 159.32K$ 180.12K
Stockholders' Equity$ ―$ ―$ ―
Cash Flow
Free Cash Flow
Operating Cash Flow$ -924.14K$ -983.68K$ -311.51K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Origin Therapeutics Holdings, Inc. Earnings and Revenue History

Origin Therapeutics Holdings, Inc. Debt to Assets

Origin Therapeutics Holdings, Inc. Cash Flow

Origin Therapeutics Holdings, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis